TSX:AEZS - Post Discussion
Post by
prophetoffactz on Jun 29, 2024 3:05pm
Steps 1 to 4: Methodical Advancement of PGX
1) Prove Up Use Cases: - PGX-YBG immune booster; - PGX-YBG/CoQ10; - Inhaled delivery: PGX-YBG/Fibrosis; - PGX/wound healing; - PGX-YBG/CoQ10 Juvente; - PGX/avenanthramide, etc. 2) PGX Scale-up: 5X scale-up to 50L and Health Canada approval for first PGX product. The scale-up to 50L also allows commercial partners to work with PGX. 10X scale-up to 100L with industry leader NATEX. This is the decision point for mass industrialization of PGX. 3) Optimize Company to Bring Transformational Products to Market: Ronald W. Miller, Chair of the Company: “With the successful completion of this merger, we are now optimized to bring value-driving, transformational products to the market.” 4) Partnerships: "This next phase of scale up will allow us to work with commercial partners in nutraceuticals and pharmaceuticals to formulate, test, and commercialize novel products and formulations, including novel functional foods and beverages, novel drugs and various forms of delivery systems,” said Gilles Gagnon, M.Sc., MBA, President and CEO." Nov. 2022 news release
Be the first to comment on this post